Weekly Digest – March 2025 Weekly Digest – March 2025 10 Mar 2025: Immunome doses first patient in Phase 1 trial of IM-1021, a ROR1-targeted ADC Immunome, Inc. has initiated the Phase 1, first-in-human trial of IM-1021, a ROR1-targeted ADC, […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id